Plus de 40 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
European Human Biomonitoring Initiative (HBM4EU)
Date du début: 1 janv. 2017, Date de fin: 31 déc. 2021,
The overarching goal of the European Human Biomonitoring Initiative (HBM4EU) is to generate knowledge to inform the safe management of chemicals and so protect human health. We will use human biomonitoring to understand human exposure to chemicals and resulting health impacts and will communicate with policy makers to ensure that our results are exploited in the design of new chemicals policies an ...
Voir le projet
43
Participants partenaires
TERMINÉ
Cofund on Biotechnologies (CoBioTech)
Date du début: 1 déc. 2016, Date de fin: 30 nov. 2021,
"The ERA-Net “Cofund on BioTechnologies” (CoBioTech) aims to better use synergies between current mechanisms of biotechnology research funding in Europe, to highlight the benefits of a bio-based economy for society, and to thus maintain and strengthen Europe’s global lead in modern biotechnology.The co-funded call will focus on application-oriented research in:a) Synthetic biology approaches to de ...
Voir le projet
22
Participants partenaires
TERMINÉ
ERA-NET ON NANOMEDICINE (EuroNanoMed III)
Date du début: 1 nov. 2016, Date de fin: 31 oct. 2021,
Nanomedicine is the application of nanotechnology to medicine and healthcare. The field takes advantage of the physical, chemical and biological properties of materials at the nanometer scale to be used for a better understanding of the biological mechanisms of diseases at the molecular level, leading to new targets for earlier and more precise diagnostics and therapeutics. Nanomedicine, rated amo ...
Voir le projet
25
Participants partenaires
TERMINÉ
EXpansion of the European Joint Programming Initiative on Drug Resistance to Antimicrobials (EXEDRA)
Date du début: 1 janv. 2017, Date de fin: 31 déc. 2020,
EXEDRA, an EXpansion of the European Joint Programming Initiative on Drug Resistance to Antimicrobials, will build on, and further support the structure and activities of JPIAMR to address the two major objectives of HCO-04-2016 topic: extending JPIAMR globally and creating a long-term sustainable structure for future expansion and governance which will coordinate national funding and collaborativ ...
Voir le projet
15
Participants partenaires
TERMINÉ
ERA NET NEURON in the area of brain-related diseases and disorders of the nervous system (NEURON Cofund)
Date du début: 1 janv. 2016, Date de fin: 31 déc. 2020,
The ERA-NET NEURON Cofund will coordinate and align European and international research funding programmes in the area of brain-related diseases and disorders of the nervous system. Key activity is the implementation of an EC co-funded joint transnational call for research proposals. The mission of NEURON is based on the fact that disorders of the brain are the major cause for impaired quality of ...
Voir le projet
22
Participants partenaires
TERMINÉ
ERA-NET for establishing synergies between the Joint Programming Initiative on Antimicrobial Resistance Research and Horizon 2020 (JPI-EC-AMR)
Date du début: 1 nov. 2015, Date de fin: 31 oct. 2020,
Antibiotic resistance is a global problem. It is considered by the World Health Organization as one of the three greatest threats to human health for the next decades. ’Enhanced coordination across national boundaries is needed to accelerate the efforts to tackle this grand challenge. Such synergies have been created among 19 countries in Europe and beyond through the EU JPI on Antimicrobial Resis ...
Voir le projet
19
Participants partenaires
TERMINÉ
ERA-NET on cardiovascular diseases to implement joint transnational research projects and set up international cooperations (ERA-CVD)
Date du début: 1 oct. 2015, Date de fin: 30 sept. 2020,
Cardiovascular diseases (CVD) are the largest cause of death in the EU and account for around 2 million deaths per year. Overall, CVD are estimated to cause the economy of the EU costs of almost 196 billion Euros a year. Furthermore, they are one of the leading causes of long term sickness, chronic diseases and loss to the labour market. Therefore, CVD are a major health problem in Europe. Despite ...
Voir le projet
23
Participants partenaires
TERMINÉ
Automated diagnostic platform, data management system and innovative communication tool, for improving the impact of malaria vector control interventions (DMC-MALVEC)
Date du début: 1 févr. 2016, Date de fin: 31 janv. 2020,
Malaria is a life-threatening disease causing more than 500,000 deaths every year in sub-Saharan Africa. Prevention of the disease is best achieved by vector control which relies on the use of insecticides. Monitoring mosquito vector populations is an integral component of control programmes and a prerequisite for effective interventions. Several individual methods are used for this task, However, ...
Voir le projet
10
Participants partenaires
TERMINÉ
ERA-NET: Aligning national/regional translational cancer research programmes and activities (TRANSCAN-2)
Date du début: 1 janv. 2015, Date de fin: 31 déc. 2019,
Cancer is a worldwide health burden and represents a major public health challenge in Europe. It is responsible for 25% of all deaths, being the second most common cause of death after cardio-vascular diseases and the main cause of mortality among people aged 45–64. Today, an estimated 9 million individuals in Europe live with cancer (Globocan 2008, http://globocan.iarc.fr/). Cancer became a chron ...
Voir le projet
30
Participants partenaires
TERMINÉ
ERACoSysMed - Collaboration on systems medicine funding to promote the implementation of systems biology approaches in clinical research and medical practice (ERACoSysMed)
Date du début: 1 janv. 2015, Date de fin: 31 déc. 2019,
Systems medicine is a new approach which integrates biological and medical data with mathematical and computational modelling in order to understand the underlying mechanisms of disease and to develop new strategies for individualised diagnosis, treatment and prevention. Systems medicine can fill the gap between experimental data produced by modern technologies and medical knowledge. Through the i ...
Voir le projet
15
Participants partenaires
TERMINÉ
ERA-NET for establishing synergies between the Joint Programming on Neurodegenerative Diseases Research and Horizon 2020 (JPco-fuND)
Date du début: 1 janv. 2015, Date de fin: 31 déc. 2019,
Over 12 million people in Europe suffer from neurodegenerative diseases (ND), yet treatments that prevent or stop the progression of neurodegeneration are still lacking. Tackling this grand challenge requires enhanced coordination of national efforts to accelerate discovery. Such synergies have been created among 28 countries in the pilot EU JPI on Neurodegenerative Disease Research (JPND). JPND h ...
Voir le projet
26
Participants partenaires
TERMINÉ
Transfer of Organisational innovations for Resilient, Effective, equitable, Accessible, sustainable and Comprehnsive Health Services and Systems. (TO-REACH)
Date du début: 1 déc. 2016, Date de fin: 30 nov. 2019,
In order to strengthen the sustainability and resilience of health services and systems a unique consortium of governmental and funding organizations plus research institutes, has expressed the ambition to systematically learn from the organisation of care in other settings. Overall objective of TO-REACH is to provide groundwork for an ERA-NET that will contribute to the resilience, effectiveness, ...
Voir le projet
31
Participants partenaires
TERMINÉ
ERA-NET rare disease research implementing IRDiRC objectives (E-Rare-3)
Date du début: 1 déc. 2014, Date de fin: 30 nov. 2019,
Rare diseases (RD) are diseases that affect not more than 5 per 10 000 persons (according to the EU definition). 7000 distinct rare diseases exist, affecting between 6% and 8% of the population (about 30 million EU citizens). The lack of specific health policies for rare diseases and the scarcity of the expertise, translate into delayed diagnosis, few medicinal products and difficult access to car ...
Voir le projet
27
Participants partenaires
TERMINÉ
Tobacco cessation within TB programmes: A ‘real world’ solution for countries with dual burden of disease (TB and Tobacco)
Date du début: 1 nov. 2015, Date de fin: 31 oct. 2019,
We aim to reduce the burden of tobacco-related lung diseases. Our approach is to integrate inexpensive tobacco cessation strategies of proven efficacy into TB control programmes. This has three advantages: a) Preventing non-communicable diseases as well as reducing TB-related deaths; b) TB patients are more likely to quit tobacco than healthy smokers – ‘teachable moments’; and c) in the absence of ...
Voir le projet
10
Participants partenaires
TERMINÉ
EuroMix
Date du début: 15 mai 2015, Date de fin: 14 mai 2019,
Euromix aim to develop an experimentally verified, tiered strategy for the risk assessment of mixtures of multiple chemicals derived from multiple sources across different life stages. The project takes account of the gender dimension and balances the risk of chemicals present in foods against the benefits of those foods.Important concepts for this new strategy are prioritisation criteria for chem ...
Voir le projet
26
Participants partenaires
TERMINÉ
European Virus Archive goes global (EVAg)
Date du début: 1 avr. 2015, Date de fin: 31 mars 2019,
The overall objective will be to create and mobilise an International network of high calibre centres around a strong European group of institutes selected for their appropriate expertises, to collect, amplify, characterise, standardise, authenticate, distribute and track, mammalian and other exotic viruses. The network of EVAg laboratories including 25 institutions represents an extensive range o ...
Voir le projet
27
Participants partenaires
TERMINÉ
Continuous Regional Analysis Device for neonate Lung (CRADL)
Date du début: 1 janv. 2016, Date de fin: 31 déc. 2018,
Each year 15 million babies are born prematurely and many suffer from respiratory failure due to immaturity of the lung and lack of control of breathing. Although respiratory support, especially mechanical ventilation, can improve their survival, it also causes severe injury to the vulnerable lung resulting in severe and chronic pulmonary morbidity lasting in to adulthood. Heterogeneity of lung ae ...
Voir le projet
11
Participants partenaires
TERMINÉ
Modernizing Health Education in Universities
Date du début: 15 oct. 2015, Date de fin: 14 oct. 2018,
Overall wider objective of the project is supporting public health in Uzbekistan by modernization of Curriculum of Health Sciences in universities of Uzbekistan and Kazakhstan and therefore following steps will be undertaken: adapting, modernizing, restructuring health sciences education, and bring innovative teaching technologies into training process as multimedia and audio-visual components; el ...
Voir le projet
15
Participants partenaires
TERMINÉ
IT-Based International Diploma and Professional Certificate in Clinical Toxicology
Date du début: 15 oct. 2015, Date de fin: 14 oct. 2018,
An IT-based, multi-disciplinary diploma accompanied with 4 professional certificate programs in clinical toxicology targeting both pharmacists, physicians (and nurses in the certificate programs) in a cross-cutting education discipline is at hand with a goal to introduce a new line of qualified professionals capable to manage, attend and deal with increasing threat of natural and synthetic poisons ...
Voir le projet
10
Participants partenaires
TERMINÉ
Public Health and Health Care in the European Union
Date du début: 1 sept. 2015, Date de fin: 31 août 2018,
...round at the Higher School of Health Administration, which is a part of the leading institution of higher medical education in Russia – I.M. Sechenov First Moscow State Medical University under the Ministry of Health of Russia.Project outputs will include 3 training courses, each course for 100 students, within 3 consecutive years (2015-2017). We will provide the course to those enrolled in existi ...
Voir le projet
1
Participant partenaire
TERMINÉ
Reaching out and linking in: Heath systems and close-to-community services (REACHOUT)
Date du début: 1 févr. 2013, Date de fin: 31 janv. 2018,
"Countries striving to provide universal health care coverage and achieve the Millennium Development Goals are increasingly implementing close-to-community (CTC) health services. There is a need for health systems to understand the context and conditions in which these services operate in order to realise their potential. Working with some of the most respected and widely quoted close-to-communi ...
Voir le projet
9
Participants partenaires
TERMINÉ
European Research Infrastructures for Poverty Related Diseases (EURIPRED)
Date du début: 1 nov. 2013, Date de fin: 31 oct. 2017,
HIV/AIDS, Tuberculosis (TB) and Malaria alone account for more than six million deaths worldwide every year. Despite substantial efforts made in recent years, Poverty Related Diseases are still spreading. New therapeutic interventions are therefore urgently required to combat Poverty Related Diseases. The existence of a well-developed HIV/TB/Malaria infrastructure presents a prime opportunity to a ...
Voir le projet
18
Participants partenaires
TERMINÉ
Strengthening Tobacco Cessation Services in Malta
Date du début: 1 juin 2016, Date de fin: 30 juin 2017,
...ng diseases. This project deals with the training of health professionals involved in the provision of smoking cessation services within the Health Promotion and Disease Prevention Directorate of the Ministry responsible for Health. The training will be undertaken at the Department of Health Promotion and Improvement of the Health Service Executive in Dublin, Ireland. Through this project, the par ...
Voir le projet
2
Participants partenaires
TERMINÉ
IMproving Preparedness and Response of HEalth Services in major criseS (IMPRESS)
Date du début: 1 mai 2014, Date de fin: 30 avr. 2017,
There exists a huge variety in the occurrence and characteristics of major incidents. Incident management stakeholders and in particular emergency health service providers have to deal with two basic challenges: The disproportion between the needs and the available human/material resources in the response capacity and the inherent time constraints of an emergency. These critical factors play a sem ...
Voir le projet
12
Participants partenaires
TERMINÉ
Coordinating Action Systems Medicine – Implementation of Systems Medicine across Europe (CASYM)
Date du début: 1 nov. 2012, Date de fin: 30 avr. 2017,
The aim of CASyM is a combined large scale effort to sustainably implement Systems Medicine across Europe. For that purpose CASyM will function as a managing and coordinating platform in bringing together a critical mass of relevant European stakeholders such as Systems Biology scientists, clinicians, programme managers, industry/SMEs as well as healthcare providers and patient organizations. The ...
Voir le projet
24
Participants partenaires
TERMINÉ
MAnagement of mental health diSorders Through advancEd technology and seRvices – telehealth for the MIND (MASTERMIND)
Date du début: 1 mars 2014, Date de fin: 28 févr. 2017,
The MastermMind Consortium to avoid dispersing efforts has narrowed the scope of the services to just one, non-organic, mental disorder: depression. This because of its high incidence, social cost and proven clinical effectiveness of ICT in its treatment. MasterMind intends: 1) to implement at scale (almost 5.000 patient overall) evidence based computerised Cognitive Behavioural Therapy (cCBT) ser ...
Voir le projet
23
Participants partenaires
TERMINÉ
Advancing SSA-EU cooperation in research and innovation for global challenges (CAAST-Net Plus)
Date du début: 1 janv. 2013, Date de fin: 31 déc. 2016,
In 2007, heads of state and government from Africa and Europe launched the Joint Africa-EU Strategy (JAES) formulated in response to geopolitical changes, globalisation and the processes of integration in Africa and Europe. At the heart of the JAES is an overtly political relationship and among the features distinguishing JAES from previous Africa-Europe policy initiatives is the associated actio ...
Voir le projet
27
Participants partenaires
TERMINÉ
Coordination of European funding for infectious diseases research (Infect-ERA)
Date du début: 1 janv. 2013, Date de fin: 31 déc. 2016,
Infectious diseases (ID) also known as communicable diseases are one of the majorcauses of death worldwide. Every year in Europe, infectious diseases cause tens of thousands of deaths (from ECDC ‘Microbes without borders: key facts on infectious diseases in Europe’ 2007 report).In order to address the challenges in ID and design adapted treatments, as well as diagnostic and preventive tools, the f ...
Voir le projet
19
Participants partenaires
TERMINÉ
EUROpean network for transnational collaborative RTD projects in the field of NANOMEDicine (EURONANOMED II)
Date du début: 1 nov. 2012, Date de fin: 31 oct. 2016,
Nanomedicine, the application of nanotechnology to health, is a fast-growing field with a large potential for improving diagnostics and therapeutic solutions in many diseases. The EuroNanoMed II (ENM II) consortium, with 20 partners from 17 countries and regions, aims to foster the competitiveness of European nanomedicine actors through the support of translational research projects enhancing tran ...
Voir le projet
25
Participants partenaires
TERMINÉ
Genetic studies of pre-eclampsia in Central Asian and European populations (INTERPREGGEN)
Date du début: 1 nov. 2011, Date de fin: 31 oct. 2016,
Pre-eclampsia, one of the most dangerous cardiometabolic complications of pregnancy, claims the lives of 50,000 mothers and almost one million babies annually. Pre-eclampsia and other hypertensive disorders of pregnancy remain the second most common cause of maternal death. The incidence of pre-eclampsia in Central Asian countries is over twice as high as in western Europe. Inter-population differ ...
Voir le projet
13
Participants partenaires
TERMINÉ
Promoting gender equality in research institutions and the integration of the gender dimension in research contents (GENDER-NET)
Date du début: 15 oct. 2013, Date de fin: 14 oct. 2016,
Despite more and more solid indicators, extensive research, policy initiatives at European and national levels, and wide awareness-raising on the issues linked to gender and science, the European Research Area is still confronted to structural obstacles within its research institutions which prevent the ERA from reaching its objectives on the full participation of women in research and innovation ...
Voir le projet
13
Participants partenaires
TERMINÉ
DEferiprone Evaluation in Paediatrics (DEEP)
Date du début: 1 janv. 2011, Date de fin: 31 août 2016,
"β-thalassaemia major is one of the most severe forms of chronic congenital anaemia. The recommended treatment consists in regular blood transfusions combined with chelating therapy to remove harmful iron accumulation in the body. The use of deferoxamine, the first chelating agent only available for subcutaneous administration is limited due to toxicity and the lack of compliance, despite its sat ...
Voir le projet
18
Participants partenaires
TERMINÉ
Innovative tools and strategies for surveillance and control of dengue (DengueTools)
Date du début: 1 sept. 2011, Date de fin: 30 avr. 2016,
Current surveillance systems and control efforts are clearly insufficient to combat dengue in endemic countries and to prevent spread to previously uninfected areas (including Europe). We will focus on the following aspects of the call: better diagnosis, surveillance, prevention as well as prediction and/or prevention of the spread of Dengue fever to previously uninfected regions (including Europe ...
Voir le projet
14
Participants partenaires
TERMINÉ
Coordination Action for the early implementation of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR)
Date du début: 1 sept. 2012, Date de fin: 29 févr. 2016,
This Coordination and Support Action proposal aims at aiding the implementation of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). JPIAMR currently has 18 participating countries and organisations from 8 of these are active partners of the CSA consortium. This proposal describes in detail the different work packages (WPs) that have been suggested in order to secure the rapid ...
Voir le projet
11
Participants partenaires
TERMINÉ
Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA)
Date du début: 1 févr. 2011, Date de fin: 31 janv. 2016,
"Chronic hepatitis B virus (HBV) infection affects 350 million people worldwide and 25-30% of these individuals will die as a result of their infection mainly as a results of hepatocellular carcinoma HCC. Liver cirrhosis, high viral load and dietary exposure to aflatoxin are recognised as risk factors for hepatocellular carcinoma amongst HBV carriers. However, these variables do not account for al ...
Voir le projet
8
Participants partenaires
TERMINÉ
Network of European funding for Neuroscience research (ERA-NET NEURON II)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2015,
Research into the human brain and its diseases is one of the key challenges of our century, since among the many diseases affecting health, disorders of the brain are major causes for impaired quality of life. Despite some progress in understanding the molecular mechanisms of the various neurological and psychiatric disorders, research is far from being able to offer solutions how to conquer them ...
Voir le projet
24
Participants partenaires
TERMINÉ
UNIversal solutions in TElemedicine Deployment for European HEALTH care (United4Health)
Date du début: 1 janv. 2013, Date de fin: 31 déc. 2015,
United4Health aims to exploit and further deploy innovative telemedicine services implemented and trialled under the RENEWING HEALTH project. A limited number of interventions have been selected from the basket of those already validated or under validation in RENEWING HEALTH; they will be trialled in 14 regions to guarantee aggregation of data and comparability of results. All service solutions a ...
Voir le projet
33
Participants partenaires
TERMINÉ
Adopting Hospital Based Health Technology Assessment in EU (AdHopHTA)
Date du début: 1 sept. 2012, Date de fin: 30 nov. 2015,
The use of HTA as a part of the decision-making process at national, regional, and international levels has evolved considerably over the past 35 years. However, still an important number of good-value innovative HTs never reach clinical practice while, in many instances, others with no significant added value actually do. This situation can be effectively overcome by approaching HTA at hospital l ...
Voir le projet
11
Participants partenaires
TERMINÉ
Quantifying projected impacts under 2°C warming (IMPACT2C)
Date du début: 1 oct. 2011, Date de fin: 30 sept. 2015,
Political discussions on the European goal to limit global warming to 2°C demands that discussions are informed by the best available science on projected impacts and possible benefits. IMPACT2C enhances knowledge, quantifies climate change impacts, and adopts a clear and logical structure, with climate and impacts modelling, vulnerabilities, risks and economic costs, as well as potential respons ...
Voir le projet
29
Participants partenaires
TERMINÉ
Italia Malta Genome Breast Cancer Cross Border Risk Surveillance (ImaGenX)
Date du début: 17 mars 2013, Date de fin: 16 sept. 2015,
...a dei tumori Achievements: Guided by the Screening Unit of the Ministry for Energy and Health of Malta, the projects partners dealt with monitoring the life style and the environmental and genetic profile of Sicilian and Maltese women of any age to identify possible ge ...
Voir le projet